Article History
Accepted: 7 February 2024
First Online: 7 March 2024
Declarations
:
: None.
: Dr. Murase is on the speakers board for Non-Branded Disease State Management Talks for UCB and Regeneron, has served on advisory boards for Sanofi-Regeneron and Bristol-Myers Squibb, and has provided dermatological consulting services for UCB, AbbVie, and UpToDate. Dr. Keri and Mr. Rau have no conflicts to declare.
: Institutional review board approval status: Exempt.
: The first draft of the manuscript was written by AR, and critical revisions were done by JK and JM. All authors read and approved the final manuscript.